
-
Stock markets, dollar rise on EU-US trade deal
-
England's Lionesses head home to party after Euro glory
-
Philippine flooding centre stage at Marcos state of nation speech
-
Thailand and Cambodia agree truce after five days of fighting
-
Israeli settlers attack West Bank Christian village
-
Food arrives in Gaza after Israel pauses some fighting
-
Starmer to press Trump on Gaza, trade in Scotland talks
-
Jamie Overton added to England squad for fifth Test against India
-
China to offer childcare subsidies in bid to boost birth rate
-
Artists, scientists breathe life into prehistoric woman
-
Iconic French chef stakes reputation on vegan menu
-
CK Hutchison eyes 'major' Chinese investor for Panama ports deal
-
England's remarkable Euro 2025 success a triumph for 'incredible' Wiegman
-
Maduro's party sweeps Venezuela mayoral vote as opposition boycotts
-
Thailand and Cambodia begin truce talks as fighting drags on
-
Stock markets boosted after EU, US strike trade deal
-
Four killed as heavy rain, flooding soaks northern China
-
Heineken sees beer sales dip but keeps profit outlook
-
China's Pan puzzled after shock 200m free exit at swimming worlds
-
Honkytonk Kenya: Africa's home of country music
-
Head of China's Shaolin Temple removed over embezzlement claims
-
Tunisia plastic collectors spread as economic, migration woes deepen
-
China's birthplace of kung fu rocked by embezzlement probe
-
Europe hopes for 'no surprises' as US weighs force withdrawals
-
France's long wait for Tour winner goes on but Thevenet sees hope
-
Most markets rise, euro boosted after EU strikes US trade deal
-
US tariff tussles stuff of nightmares for Bordeaux winemakers
-
Taiwan's garbage trucks offer classical music and a catch-up
-
Thailand and Cambodia truce talks due but strikes continue
-
De Minaur battles to DC Open crown
-
US-China set to meet with extension of tariff pause on the cards
-
What is the status of US tariff negotiations?
-
State of play in Trump's tariffs, threats and delays
-
UN tackles beleaguered two-state solution for Israel, Palestinians
-
Wallabies call up former All Black prop Ross for third Lions Test
-
Australia rugby boss seeks answers on controversial Lions try
-
Monfils says Toronto loss marks his final Toronto visit
-
Toronto top seed Zverev got expert insight from retired rival Rafa
-
Kitayama captures PGA 3M Open title with big birdie weekend
-
George Lucas brings the force to Comic-Con in historic first visit
-
Palou wins eighth IndyCar title of year at Monterey Grand Prix
-
Three things we learned from the fourth Test between England and India
-
England hero Kelly overcomes 'dark moments' on way to Euro 2025 glory
-
Three dead, several injured after train derails in Germany
-
What we know so far about the EU-US trade deal
-
Spain deserved better in Euro 2025 final, says coach
-
King Charles salutes Lionesses after England's historic Euro glory
-
Stokes ready to 'run through brick wall' to feature in India decider
-
Fernandez dominates Kalinskaya to win DC Open
-
Wiegman hails 'incredible' Euros repeat for England
RBGPF | -1.52% | 73.88 | $ | |
RIO | -1.16% | 63.1 | $ | |
NGG | -0.11% | 72.15 | $ | |
CMSC | 0.24% | 22.485 | $ | |
SCS | 0.66% | 10.58 | $ | |
BCC | 1.94% | 88.14 | $ | |
AZN | -1.4% | 72.66 | $ | |
RELX | -1.86% | 52.73 | $ | |
GSK | -0.68% | 37.97 | $ | |
BCE | -0.95% | 24.2 | $ | |
SCU | 0% | 12.72 | $ | |
CMSD | 0.17% | 22.89 | $ | |
RYCEF | -0.3% | 13.2 | $ | |
BTI | -0.71% | 52.25 | $ | |
VOD | -0.79% | 11.43 | $ | |
JRI | -0.46% | 13.09 | $ | |
BP | 0.22% | 32.2 | $ |

Lab-grown human 'embryos' offer new research hope
Scientists have developed human embryo-like structures without using sperm, an egg or fertilisation, offering hope for research on miscarriage and birth defects but also raising fresh ethical concerns.
Earlier this year, several labs around the world released pre-print studies describing their development of early human embryo-like structures.
That work has not yet been peer-reviewed, but now one group's research has been published in the journal Nature, describing how they coaxed human embryonic stem cells to self-organise into a model resembling an early embryo.
The research was welcomed by some scientists as an "impressive" advance that could help unlock secrets about the precarious early stages of pregnancies, when failure is most common.
The work will however renew debate on the need for clearer ethical rules on development of lab-grown human embryo models.
The researchers, led by Palestinian scientist Jacob Hanna at the Weizmann Institute in Israel, harnesses the power of embryonic stem cells, which can become any kind of cell.
They produced embryo models up to 14 days old, which is the legal limit for such research in many countries, and the point at which organs like the brain begin to develop.
The researchers say their work differs from those of other teams because it uses chemically rather than genetically modified embryonic stem cells and produces models more like real human embryos, complete with yolk sac and amniotic cavity.
These similarities could make the models more useful for research into conditions like miscarriage, birth defects and infertility, said James Briscoe of Britain's Francis Crick Institute.
The model "seems to produce all of the different types of cells that form tissues at this early stage of development," said Briscoe, principal group leader and associate research director at the biomedical research charity.
The research "is a step towards opening a window on the period of human development where many pregnancies fail and which has been really difficult to study up until now."
Both the researchers and scientists not involved in the work emphasised that the models should not be considered human embryos.
The structure "highly resembles, but (is) not identical, to the in utero situation", the research notes.
The success rate on generating the models was also low, with the stem cells organising correctly just a small percentage of the time.
Still, the research and other recent work shows "that models of human embryos are getting more sophisticated and closer to events that occur during normal development," said Darius Widera, an expert in stem cell biology at the UK's University of Reading.
The work highlights "that a robust regulatory framework is more needed than ever before", he added.
In Britain, Cambridge University has begun developing the first governance framework for stem cell-based human embryo models.
The Weizmann Institute research does not involve transferring the models into a human or animal womb, or developing the structures beyond 14 days.
L.Janezki--BTB